Moderna to supply 35 million more doses of its COVID-19 vaccine to Taiwan in 2022 and 2023

Shares of Moderna Inc. gained 0.3% in trading on Thursday after the company said Taiwan purchased another 35 million doses of its COVID-19 vaccine. The deal could also include Moderna's variant booster shot if and when it is authorized. Twenty million doses are expected to be delivered in 2022 and another 15 million in 2023. Moderna's stock has jumped 209.8% since the beginning of the year, while the broader S&P 500 is up 15.1%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.